These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of stereochemical aspects on drug interaction in pharmacokinetics. Zhou Q; Yao TW; Zeng S Acta Pharmacol Sin; 2002 May; 23(5):385-92. PubMed ID: 11978187 [TBL] [Abstract][Full Text] [Related]
4. [Chirality and drugs]. Testa B; Reist M; Carrupt PA Ann Pharm Fr; 2000 Jul; 58(4):239-46. PubMed ID: 10915971 [TBL] [Abstract][Full Text] [Related]
5. [Mirror, mirror on the wall--stereoselectivity of drug effects]. Fromm MF; Kroemer HK Fortschr Med; 1995 Aug; 113(24):343-5. PubMed ID: 7590555 [No Abstract] [Full Text] [Related]
6. [Stereochemistry and drug effects--a neglected field of knowledge]. Reis M; Kugelberg FC; Carlsson B; Josefsson M; Waldeck B Lakartidningen; 2006 Apr 26-May 2; 103(17):1305-6, 1309-11. PubMed ID: 16708858 [No Abstract] [Full Text] [Related]
7. [Optical isomers in medicine (review of foreign literature)]. Starostin BD Voen Med Zh; 2003; 324(4):25-9. PubMed ID: 12825362 [No Abstract] [Full Text] [Related]
8. Chirality and drugs in clinical practice and its ethical aspect. Banerjee M; Biswas I; Halder S J Indian Med Assoc; 2009 Jan; 107(1):41-2. PubMed ID: 19588688 [TBL] [Abstract][Full Text] [Related]
10. Generic substitution: the use of medicinal products containing different salts and implications for safety and efficacy. Verbeeck RK; Kanfer I; Walker RB Eur J Pharm Sci; 2006 May; 28(1-2):1-6. PubMed ID: 16413762 [TBL] [Abstract][Full Text] [Related]
11. [Drug interactions in the practice. Which combinations are taboo?]. Zolk O; el-Armouche A; Eschenhagen T MMW Fortschr Med; 2001 Dec; 143(51-52):24-32. PubMed ID: 11824161 [No Abstract] [Full Text] [Related]
12. [Individualize drug therapy!]. Vitols S Lakartidningen; 1997 Feb; 94(6):444-5. PubMed ID: 9053696 [No Abstract] [Full Text] [Related]
13. Drugs in old age: new perspectives. Br Med Bull; 1990 Jan; 46(1):1-291. PubMed ID: 2302525 [No Abstract] [Full Text] [Related]
14. [Drug therapy in the elderly: limiting to the essentials]. Hoffmann F; Meyer F Pflege Z; 2005 May; 58(5):282-6. PubMed ID: 15945570 [No Abstract] [Full Text] [Related]
15. Drug disposition in three dimensions: an update on stereoselectivity in pharmacokinetics. Brocks DR Biopharm Drug Dispos; 2006 Nov; 27(8):387-406. PubMed ID: 16944450 [TBL] [Abstract][Full Text] [Related]
16. An integrated, multidisciplinary approach for drug safety assessment. Li AP Drug Discov Today; 2004 Aug; 9(16):687-93. PubMed ID: 15341779 [No Abstract] [Full Text] [Related]
17. A consideration of the patentability of enantiomers in the pharmaceutical industry in the United States. Miller CP; Ullrich JW Chirality; 2008 Jun; 20(6):762-70. PubMed ID: 18200591 [TBL] [Abstract][Full Text] [Related]
18. Enantiospecific analysis by capillary electrophoresis: applications in drug metabolism and pharmacokinetics. Hadley MR; Camilleri P; Hutt AJ Electrophoresis; 2000 Jun; 21(10):1953-76. PubMed ID: 10879955 [TBL] [Abstract][Full Text] [Related]